Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: A Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment – Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial

Lignende værker

• Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
  af: Joseph Lewis BA, et al.
  Udgivet: (2022-05-01)
• Physicians’ Perceptions of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score in Older Adults with Acute Myocardial Infarction
  af: Feder, Shelli L., et al.
  Udgivet: (2015)
• Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
  af: Thompson David, et al.
  Udgivet: (2006-09-01)
• Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
  af: McGarry, Lisa J, et al.
  Udgivet: (2006)
• Thrombolysis in Myocardial Infarction (TIMI) Risk Score Assessment for Complications in Acute Anterior Wall ST Elevation Myocardial Infarction
  af: Khan, Rozi, et al.
  Udgivet: (2020)